Priscilla A. Furth
Affiliations: | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Genetics, Molecular Biology, Cell BiologyGoogle:
"Priscilla Furth"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Furth PA, Wang W, Kang K, et al. (2022) Overexpression of Estrogen Receptor α in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor α-Positive Mammary Adenocarcinomas. The American Journal of Pathology. 193: 103-120 |
| Furth PA, Wang W, Kang K, et al. (2022) Esr1 but Not CYP19A1 Overexpression in Mammary Epithelial Cells during Reproductive Senescence Induces Pregnancy-Like Proliferative Mammary Disease Responsive to Anti-Hormonals. The American Journal of Pathology. 193: 84-102 |
| Alothman SJ, Kang K, Liu X, et al. (2022) Characterization of transcriptome diversity and in vitro behavior of primary human high-risk breast cells. Scientific Reports. 12: 6159 |
| Saenz FR, Ory V, Schmidt MO, et al. (2019) Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer. Neoplasia (New York, N.Y.). 21: 963-973 |
| Furth PA. (2018) Peroxisome proliferator-activated receptor gamma and BRCA1. Endocrine-Related Cancer |
| Alamri AM, Liu X, Blancato JK, et al. (2018) Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. Disease Models & Mechanisms. 11 |
| Ory V, Kietzman WB, Boeckelman J, et al. (2018) The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Research and Treatment |
| Alothman SJ, Wang W, Goerlitz DS, et al. (2017) Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus. Cancer Prevention Research (Philadelphia, Pa.) |
| Alothman SJ, Chao S, Wang W, et al. (2017) Abstract 2234: Efatutazone reduces mammosphere formation inBrca1WT/fl11/Cre/p53+/-andBrca1fl11/fl11/Cre/p53+/-mice Cancer Research. 77: 2234-2234 |
| Alamri AM, Kang K, Groeneveld S, et al. (2016) Primary cancer cell culture: mammary-optimized versus conditional-reprogramming. Endocrine-Related Cancer |